Trends in survival for patients with metastatic soft-tissue sarcoma (Q37800052)

23 August 2017

Trends in survival for patients with metastatic soft-tissue sarcoma (English)

1 reference

23 August 2017

0 references

3

Axel Le Cesne

0 references

Jean-Yves Blay

Simone Mathoulin-Pélissier

8

object named as

Jean-Yves Blay

0 references

2

object named as

Simone Mathoulin-Pelissier

1 reference

23 August 2017

9

Jean-Michel Coindre

1 reference

23 August 2017

5

Sylvie Bonvalot

1 reference

23 August 2017

Antoine Italiano

1

1 reference

23 August 2017

Philippe Terrier

4

1 reference

23 August 2017

Françoise Collin

6

1 reference

23 August 2017

Jean-Jacques Michels

7

1 reference

23 August 2017

Binh Bui

10

1 reference

23 August 2017

language of work or name

English

0 references

publication date

13 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

117

1 reference

23 August 2017

5

1 reference

23 August 2017

1049-1054

1 reference

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

23 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Molecularly targeted treatment for dermatofibrosarcoma protuberans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

7 January 2021

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

7 January 2021

Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

7 January 2021

Median follow-up in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

7 January 2021

Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

7 January 2021

Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25538

7 January 2021

Identifiers

DOI

10.1002/CNCR.25538

1 reference

release_hsedy3oggbdlhawyd3enqq4yjq

23 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hsedy3oggbdlhawyd3enqq4yjq

24 November 2022

mapped directly with Wikidata item

1 reference